CVRx (CVRX) FCF Margin Growth (1y) (2021 - 2026)
CVRx (CVRX) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 261.00 |
| 10 | CVRx | 130.46 Mn | 58.16 Mn | 12.88 Mn | 2,113.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,113.00 |
| Dec 31, 2025 | -878.00 |
| Sep 30, 2025 | 1,002.00 |
| Jun 30, 2025 | 2,710.00 |
| Mar 31, 2025 | 537.00 |
| Dec 31, 2024 | 1,830.00 |
| Sep 30, 2024 | -45.00 |
| Jun 30, 2024 | 5,006.00 |
| Mar 31, 2024 | 2,177.00 |
| Dec 31, 2023 | 8,134.00 |
| Sep 30, 2023 | 10,597.00 |
| Jun 30, 2023 | 6,532.00 |
| Mar 31, 2023 | 13,687.00 |
| Dec 31, 2022 | 5,431.00 |
| Sep 30, 2022 | 9,265.00 |
| Jun 30, 2022 | 1,747.00 |
| Mar 31, 2022 | -8,864.00 |
| Dec 31, 2021 | -605.00 |
| Sep 30, 2021 | 25,280.00 |